Market Place
Sourcing Support
All News #Library
Biotech
Tectonic Therapeutic To Participate In March Investor Conferences
02 Mar 2026 //
GLOBENEWSWIRE
Tectonic Therapeutics Hosts Virtual TX2100 Event
11 Feb 2026 //
GLOBENEWSWIRE
Tectonic Therapeutic Joins December Investor Conferences
01 Dec 2025 //
GLOBENEWSWIRE
Tectonic Therapeutic Reveals Q3 2025 Financials & Business
06 Nov 2025 //
GLOBENEWSWIRE
Tectonic Therapeutic Reports Positive Ph1b Trial Results for TX45
29 Oct 2025 //
GLOBENEWSWIRE
Tectonic Therapeutic to Present at September Investor Conferences
28 Aug 2025 //
GLOBENEWSWIRE
Tectonic Therapeutic Unveils Q2 2025 Financials and Business
07 Aug 2025 //
GLOBENEWSWIRE
Tectonic Therapeutic Joins Russell 3000® Index
30 Jun 2025 //
GLOBENEWSWIRE
Tectonic Therapeutic Presents Complete Results of TX45 Phase 1b
17 May 2025 //
GLOBENEWSWIRE
Tectonic Therapeutic to Present on May 15th, 2025 at Conference
07 May 2025 //
GLOBENEWSWIRE
Tectonic to Present Phase 1b Data for TX45 at ESC Heart Failure
15 Apr 2025 //
GLOBENEWSWIRE
Tectonic Therapeutic Announces Q4 and Full Year 2024 Results
20 Mar 2025 //
GLOBENEWSWIRE
Tectonic Therapeutic to Participate in March Investor Conferences
20 Feb 2025 //
GLOBENEWSWIRE
Tectonic Announces $185 Million Private Placement
03 Feb 2025 //
GLOBENEWSWIRE
Tectonic to Host KOL Event on Group 2 PH-HFpEF and TX45 Treatment
03 Dec 2024 //
GLOBENEWSWIRE
Tectonic Therapeutics to Present at Piper Sandler Conference Dec 3
26 Nov 2024 //
GLOBENEWSWIRE
Tectonic Presents Positive TX45 Phase 1a Results at AHA 2024
11 Nov 2024 //
GLOBENEWSWIRE
Tectonic Announces Q3 2024 Financial Results & Business Highlights
07 Nov 2024 //
GLOBENEWSWIRE
Tectonic Therapeutic to Present Phase 1a Data at AHA 2024
22 Oct 2024 //
GLOBENEWSWIRE
Tectonic Therapeutic Announces Phase 1a Results For TX45
19 Sep 2024 //
GLOBENEWSWIRE
Tectonic Therapeutic to Participate in September Investor Conferences
20 Aug 2024 //
GLOBENEWSWIRE
Tectonic Therapeutic Announces Q2 2024 Financial Results And Business Highlights
14 Aug 2024 //
GLOBENEWSWIRE
Tectonic Therapeutic Announces US IND Clearance for Lead Program, TX45
30 Jul 2024 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.